Literature DB >> 16400008

Pathophysiologic implications of reduced podocyte number in a rat model of progressive glomerular injury.

Daniela Macconi1, Maria Bonomelli, Ariela Benigni, Tiziana Plati, Fabio Sangalli, Lorena Longaretti, Sara Conti, Hiroshi Kawachi, Prue Hill, Giuseppe Remuzzi, Andrea Remuzzi.   

Abstract

Changes in podocyte number or density have been suggested to play an important role in renal disease progression. Here, we investigated the temporal relationship between glomerular podocyte number and development of proteinuria and glomerulosclerosis in the male Munich Wistar Fromter (MWF) rat. We also assessed whether changes in podocyte number affect podocyte function and focused specifically on the slit diaphragm-associated protein nephrin. Age-matched Wistar rats were used as controls. Estimation of podocyte number per glomerulus was determined by digital morphometry of WT1-positive cells. MWF rats developed moderate hypertension, massive proteinuria, and glomerulosclerosis with age. Glomerular hypertrophy was already observed at 10 weeks of age and progressively increased thereafter. By contrast, mean podocyte number per glomerulus was lower than normal in young animals and further decreased with time. As a consequence, the capillary tuft volume per podocyte was more than threefold increased in older rats. Electron microscopy showed important changes in podocyte structure of MWF rats, with expansion of podocyte bodies surrounding glomerular filtration membrane. Glomerular nephrin expression was markedly altered in MWF rats and inversely correlated with both podocyte loss and proteinuria. Our findings suggest that reduction in podocyte number is an important determinant of podocyte dysfunction and progressive impairment of the glomerular permselectivity that lead to the development of massive proteinuria and ultimately to renal scarring.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16400008      PMCID: PMC1592676          DOI: 10.2353/ajpath.2006.050398

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  45 in total

1.  Hindered transport of macromolecules through a single row of cylinders: application to glomerular filtration.

Authors:  M C Drumond; W M Deen
Journal:  J Biomech Eng       Date:  1995-11       Impact factor: 2.097

2.  Podocyte detachment and epithelial cell reaction in focal segmental glomerulosclerosis with cellular variants.

Authors:  I Kihara; S Tsuchida; E Yaoita; T Yamamoto; M Hara; T Yanagihara; T Takada
Journal:  Kidney Int Suppl       Date:  1997-12       Impact factor: 10.545

3.  Podocyte loss and progressive glomerular injury in type II diabetes.

Authors:  M E Pagtalunan; P L Miller; S Jumping-Eagle; R G Nelson; B D Myers; H G Rennke; N S Coplon; L Sun; T W Meyer
Journal:  J Clin Invest       Date:  1997-01-15       Impact factor: 14.808

4.  Glomerular permeability barrier in the rat. Functional assessment by in vitro methods.

Authors:  B S Daniels; W M Deen; G Mayer; T Meyer; T H Hostetter
Journal:  J Clin Invest       Date:  1993-08       Impact factor: 14.808

5.  Cytoskeletal changes in podocytes associated with foot process effacement in Masugi nephritis.

Authors:  I Shirato; T Sakai; K Kimura; Y Tomino; W Kriz
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

6.  Markers of complement-dependent and complement-independent glomerular visceral epithelial cell injury in vivo. Expression of antiadhesive proteins and cytoskeletal changes.

Authors:  J Floege; C E Alpers; E H Sage; P Pritzl; K Gordon; R J Johnson; W G Couser
Journal:  Lab Invest       Date:  1992-10       Impact factor: 5.662

7.  Pathophysiologic implications of proteinuria in a rat model of progressive glomerular injury.

Authors:  A Remuzzi; S Puntorieri; M Alfano; D Macconi; M Abbate; T Bertani; G Remuzzi
Journal:  Lab Invest       Date:  1992-11       Impact factor: 5.662

8.  ACE inhibition prevents renal failure and death in uninephrectomized MWF/Ztm rats.

Authors:  A Remuzzi; A Benigni; B Malanchini; I Bruzzi; C Foglieni; G Remuzzi
Journal:  Kidney Int       Date:  1995-05       Impact factor: 10.612

9.  Dissociation between antiproteinuric and antihypertensive effect of angiotensin converting enzyme inhibitors in rats.

Authors:  A Remuzzi; O Imberti; S Puntorieri; B Malanchini; D Macconi; L Magrini; T Bertani; G Remuzzi
Journal:  Am J Physiol       Date:  1994-12

10.  Nuclear localization of the protein encoded by the Wilms' tumor gene WT1 in embryonic and adult tissues.

Authors:  S Mundlos; J Pelletier; A Darveau; M Bachmann; A Winterpacht; B Zabel
Journal:  Development       Date:  1993-12       Impact factor: 6.868

View more
  54 in total

1.  Imaging of the porous ultrastructure of the glomerular epithelial filtration slit.

Authors:  Elena Gagliardini; Sara Conti; Ariela Benigni; Giuseppe Remuzzi; Andrea Remuzzi
Journal:  J Am Soc Nephrol       Date:  2010-10-28       Impact factor: 10.121

2.  Risk factors for end stage renal disease in non-WT1-syndromic Wilms tumor.

Authors:  Jane Lange; Susan M Peterson; Janice R Takashima; Yevgeny Grigoriev; Michael L Ritchey; Robert C Shamberger; J Bruce Beckwith; Elizabeth Perlman; Daniel M Green; Norman E Breslow
Journal:  J Urol       Date:  2011-06-17       Impact factor: 7.450

3.  Impact of impaired cardiac function on the progression of chronic kidney disease---role of pharmacomodulation of valsartan.

Authors:  Chih-Chao Yang; Hon-Kan Yip; Kuan-Hung Chen; Cheuk-Kwan Sun; Yen-Ta Chen; Han-Tan Chai; Pei-Hsun Sung; Hsin-Ju Chiang; Sheung-Fat Ko; Sheng-Ying Chung; Chih-Hung Chen; Kun-Chen Lin; Pao-Yuan Lin; Jiunn-Jye Sheu
Journal:  Am J Transl Res       Date:  2017-05-15       Impact factor: 4.060

Review 4.  Shiga toxin triggers endothelial and podocyte injury: the role of complement activation.

Authors:  Carlamaria Zoja; Simona Buelli; Marina Morigi
Journal:  Pediatr Nephrol       Date:  2017-12-06       Impact factor: 3.714

5.  Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension.

Authors:  Sarah F Knight; Jianghe Yuan; Siddhartha Roy; John D Imig
Journal:  Am J Physiol Renal Physiol       Date:  2009-11-11

6.  Epithelial-to-mesenchymal transition is a potential pathway leading to podocyte dysfunction and proteinuria.

Authors:  Yingjian Li; Young Sun Kang; Chunsun Dai; Lawrence P Kiss; Xiaoyan Wen; Youhua Liu
Journal:  Am J Pathol       Date:  2008-01-17       Impact factor: 4.307

7.  Angiotensin II infusion induces nephrin expression changes and podocyte apoptosis.

Authors:  Junya Jia; Guohua Ding; Jili Zhu; Cheng Chen; Wei Liang; Nicholas Franki; Pravin C Singhal
Journal:  Am J Nephrol       Date:  2008-01-17       Impact factor: 3.754

8.  Endothelial dysfunction and the development of renal injury in spontaneously hypertensive rats fed a high-fat diet.

Authors:  Sarah F Knight; Jeffrey E Quigley; Jianghe Yuan; Siddhartha S Roy; Ahmed Elmarakby; John D Imig
Journal:  Hypertension       Date:  2007-12-24       Impact factor: 10.190

9.  Shiga toxin promotes podocyte injury in experimental hemolytic uremic syndrome via activation of the alternative pathway of complement.

Authors:  Monica Locatelli; Simona Buelli; Anna Pezzotta; Daniela Corna; Luca Perico; Susanna Tomasoni; Daniela Rottoli; Paola Rizzo; Debora Conti; Joshua M Thurman; Giuseppe Remuzzi; Carlamaria Zoja; Marina Morigi
Journal:  J Am Soc Nephrol       Date:  2014-02-27       Impact factor: 10.121

10.  Deletion of CD151 results in a strain-dependent glomerular disease due to severe alterations of the glomerular basement membrane.

Authors:  Rosa M Baleato; Petrina L Guthrie; Marie-Claire Gubler; Leonie K Ashman; Séverine Roselli
Journal:  Am J Pathol       Date:  2008-09-11       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.